Short Interest in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Rises By 600.3%

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) was the target of a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 252,647 shares, an increase of 600.3% from the May 14th total of 36,079 shares. Currently, 6.2% of the company’s shares are sold short. Based on an average trading volume of 413,217 shares, the short-interest ratio is presently 0.6 days.

Hedge Funds Weigh In On Defiance Daily Target 2X Long LLY ETF

An institutional investor recently bought a new position in Defiance Daily Target 2X Long LLY ETF stock. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,433 shares of the company’s stock, valued at approximately $138,000. Thurston Springer Miller Herd & Titak Inc. owned about 0.34% of Defiance Daily Target 2X Long LLY ETF as of its most recent SEC filing.

Defiance Daily Target 2X Long LLY ETF Price Performance

Defiance Daily Target 2X Long LLY ETF stock traded down $0.38 during mid-day trading on Wednesday, hitting $25.19. The stock had a trading volume of 325,660 shares, compared to its average volume of 482,696. The stock has a 50-day simple moving average of $19.47 and a two-hundred day simple moving average of $21.91. Defiance Daily Target 2X Long LLY ETF has a 12 month low of $9.60 and a 12 month high of $28.44.

Defiance Daily Target 2X Long LLY ETF Company Profile

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.